Add to a list

Inactive Instrument

ICAD Share Price

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Analysts' recommendations: ICAD

17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
17/04/25	BTIG Research Downgrades iCAD to Neutral From Buy	MT
19/07/23	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
13/04/23	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
04/04/23	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

More recommendations

iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Stock Market
Stocks
ICAD Stock

The best tools reserved for subscribers to boost the performance of your investments!

21/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Benchmark Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Benchmark	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Growth Benchmark	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Index	CI
17/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Index	CI
17/07/25	RadNet, Inc. completed the acquistion of iCAD, Inc..	CI
17/07/25	RadNet's DeepHealth Unit Closes iCAD Acquisition	MT
16/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from NASDAQ Composite Index	CI
13/05/25	ICAD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

08/07/25	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
03/06/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
13/05/25	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
29/04/25	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
17/04/25	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

13/03/23	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
26/04/21	CAC 40 : Les valeurs à suivre à Paris et en Europe
26/04/21	Les valeurs à suivre à Paris et en Europe (actualisé)
18/10/19	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
25/01/19	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

3 years	1.18	4.02
5 years	1.05	11.78
10 years	1.05	21.44

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	09/03/2023
Mark Stolper DFI	Director of Finance/CFO	54	16/07/2025
Dave Katz SEC	Corporate Secretary	-	16/07/2025

ICAD Share Price

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Latest news: ICAD

Analysts' recommendations: ICAD

Press Releases: ICAD

News in other languages: ICAD

Quotes and Performance

Price Extremes

Managers and Directors: ICAD

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
17/07/25	Andrew Sassine	Issuer sale	Director	1,553,657	5.8540%
17/07/25	Eric Lonnqvist	Issuer sale	Chief Financial Officer	158,488	0.5972%
17/07/25	Jonathan Go	Issuer sale	Chief Technology Officer	351,145	1.3231%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICAD	+3.75%	-.--%	-	-	106M
THERMO FISHER SCIENTIFIC, INC.	+1.12%	+0.29%	+24.93%	+55.29%	262B
DANAHER CORPORATION	+2.09%	+0.37%	+9.87%	+18.73%	165B
INTUITIVE SURGICAL, INC.	+9.38%	+8.54%	-10.53%	+73.09%	167B
BOSTON SCIENTIFIC CORPORATION	+5.33%	+7.99%	-53.64%	-12.77%	66.41B
EDWARDS LIFESCIENCES CORPORATION	+4.39%	+8.27%	+18.09%	+48.16%	57.28B
SIEMENS HEALTHINEERS AG	-1.87%	+2.45%	-2.36%	-7.63%	56.02B
AGILENT TECHNOLOGIES, INC.	+0.97%	-2.37%	+21.28%	+62.51%	49.95B
VEEVA SYSTEMS INC.	+2.45%	-2.26%	+5.84%	+59.63%	50.29B
WATERS CORPORATION	+1.67%	-1.95%	+27.29%	+79.51%	45.94B
Average	+1.39%	+2.17%	+4.53%	+41.84%	102.22B
Weighted average by Cap.	+0.73%	+2.34%	+6.90%	+44.60%